Lee KH - Search Results

1

Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors.

Desai J, Deva S, Lee JS, Lin CC, Yen CJ, Chao Y, Keam B, Jameson M, Hou MM, Kang YK, Markman B, Lu CH, Rau KM, Lee KH, Horvath L, Friedlander M, Hill A, Sandhu S, Barlow P, Wu CY, Zhang Y, Liang L, Wu J, Paton V, Millward M. Desai J, et al. Among authors: lee js, lee kh. J Immunother Cancer. 2020 Jun;8(1):e000453. doi: 10.1136/jitc-2019-000453. J Immunother Cancer. 2020. PMID: 32540858 Free PMC article. Clinical Trial.

2

Comparative outcomes of reduced intensity and myeloablative allogeneic hematopoietic stem cell transplantation in patients under 50 with hematologic malignancies.

Kim I, Yoon SS, Lee KH, Keam B, Kim TM, Kim JS, Kim HG, Oh MD, Han KS, Park MH, Park S, Kim BK. Kim I, et al. Among authors: lee kh. Clin Transplant. 2006 Jul-Aug;20(4):496-503. doi: 10.1111/j.1399-0012.2006.00512.x. Clin Transplant. 2006. PMID: 16842528 Clinical Trial.

3

Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.

Kim I, Keam B, Lee KH, Kim JH, Oh SY, Ra EK, Yoon SS, Park SS, Kim CS, Park S, Hong YC, Kim BK. Kim I, et al. Among authors: lee kh. Clin Transplant. 2007 Mar-Apr;21(2):207-13. doi: 10.1111/j.1399-0012.2006.00624.x. Clin Transplant. 2007. PMID: 17425746

4

Allogeneic stem cell transplantation for patients with advanced hematological malignancies: comparison of fludarabine-based reduced intensity conditioning versus myeloablative conditioning.

Kim I, Lee KH, Choi Y, Keam B, Koo NH, Yoon SS, Yoo KY, Park S, Kim BK. Kim I, et al. Among authors: lee kh. J Korean Med Sci. 2007 Apr;22(2):227-34. doi: 10.3346/jkms.2007.22.2.227. J Korean Med Sci. 2007. PMID: 17449929 Free PMC article. Clinical Trial.

5

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis.

Keam B, Im SA, Lee KH, Han SW, Oh DY, Kim JH, Lee SH, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Bang YJ. Keam B, et al. Among authors: lee sh, lee kh. Breast Cancer Res. 2011 Mar 2;13(2):R22. doi: 10.1186/bcr2834. Breast Cancer Res. 2011. PMID: 21366896 Free PMC article.

6

The prognostic significance of HER2 positivity for advanced gastric cancer patients undergoing first-line modified FOLFOX-6 regimen.

Kim JW, Im SA, Kim M, Cha Y, Lee KH, Keam B, Kim MA, Han SW, Oh DY, Kim TY, Kim WH, Bang YJ. Kim JW, et al. Among authors: lee kh. Anticancer Res. 2012 Apr;32(4):1547-53. Anticancer Res. 2012. PMID: 22493400

7

Body mass index is not associated with treatment outcomes of breast cancer patients receiving neoadjuvant chemotherapy: korean data.

Lee KH, Keam B, Im SA, Kim TY, Han SW, Oh DY, Kim JH, Lee SH, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Bang YJ. Lee KH, et al. Among authors: lee sh. J Breast Cancer. 2012 Dec;15(4):427-33. doi: 10.4048/jbc.2012.15.4.427. Epub 2012 Dec 31. J Breast Cancer. 2012. PMID: 23346172 Free PMC article.

8

ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy.

Kim HJ, Im SA, Keam B, Ham HS, Lee KH, Kim TY, Kim YJ, Oh DY, Kim JH, Han W, Jang IJ, Kim TY, Park IA, Noh DY. Kim HJ, et al. Among authors: lee kh. Cancer Sci. 2015 Jan;106(1):86-93. doi: 10.1111/cas.12560. Epub 2014 Dec 8. Cancer Sci. 2015. PMID: 25410489 Free PMC article.

9

A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer.

Kim JW, Choi IS, Kim YJ, Lee KH, Lee KW, Kim TY, Han SW, Kim JH, Kim TY, Lee JS, Bang YJ, Im SA, Oh DY. Kim JW, et al. Among authors: lee js, lee kh, lee kw. Cancer Chemother Pharmacol. 2015 Jun;75(6):1175-82. doi: 10.1007/s00280-015-2732-9. Epub 2015 Apr 10. Cancer Chemother Pharmacol. 2015. PMID: 25860347 Clinical Trial.

10

A phase I study of the human anti-activin receptor-like kinase 1 antibody PF-03446962 in Asian patients with advanced solid tumors.

Doi T, Lee KH, Kim TM, Ohtsu A, Kim TY, Ikeda M, Yoh K, Gallo Stampino C, Hirohashi T, Suzuki A, Fujii Y, Andrew Williams J, Bang YJ. Doi T, et al. Among authors: lee kh. Cancer Med. 2016 Jul;5(7):1454-63. doi: 10.1002/cam4.724. Epub 2016 Apr 14. Cancer Med. 2016. PMID: 27075560 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,005 results

Search Page

Filters